Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    11756187 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy
Condition: Chronic Myeloid Leukemia
Intervention: Biological: Autologous CIK cell infusion

Study has passed its completion date and status has not been verified in more than two years.